Huntington National Bank Sells 5,000 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Huntington National Bank lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 20.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,885 shares of the pharmacy operator’s stock after selling 5,000 shares during the quarter. Huntington National Bank’s holdings in Walgreens Boots Alliance were worth $176,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. First Financial Corp IN lifted its position in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $26,000. Riverview Trust Co lifted its holdings in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares during the period. Venturi Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $28,000. Finally, TD Private Client Wealth LLC grew its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on WBA. Royal Bank of Canada boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Bank of America boosted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Finally, Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $10.59.

Read Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $10.68 on Friday. The stock has a market capitalization of $9.23 billion, a P/E ratio of -1.04, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $19.48. The business has a 50-day moving average price of $10.75 and a two-hundred day moving average price of $9.98.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the business posted $0.66 earnings per share. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.